We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

STO:ASXSantos Limited Analysis

Data as of 2026-06-12 - not real-time

A$8.07

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook shows the short‑term average price trend sitting comfortably above both the mid‑term and long‑term averages, reinforced by a bullish MACD histogram and an RSI that remains in the upper‑mid range, indicating continued momentum. Price action is holding just above a clear support zone while facing a modest resistance ceiling, and although trading volume has been tapering, the market’s volatility is elevated, suggesting price swings may persist. Fundamentals reveal a solid dividend yield that outpaces many peers, but the payout ratio is near the upper limit, raising questions about long‑term sustainability. The company’s cash generation covers its debt obligations, yet leverage remains moderate and free cash flow, while positive, is modest relative to the dividend commitment. Valuation metrics show a forward earnings multiple that is markedly cheaper than the trailing figure, hinting at a potential re‑rating, though a discounted cash flow model points to a valuation gap that tempers optimism. Overall, the stock sits at a crossroads where bullish technical signals and attractive income are balanced against sector‑specific regulatory headwinds and a high dividend payout.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish technical alignment with moving averages and MACD
  • Proximity to a well‑defined support level
  • High dividend yield offset by a tight payout ratio

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward earnings multiple suggests upside potential
  • Strong cash flow coverage of debt and dividend
  • Attractive income profile in a stable commodity environment

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Exposure to energy transition and regulatory scrutiny
  • Moderate leverage that could limit flexibility
  • Sustainable dividend income if cash generation remains steady

Key Metrics & Analysis

Financial Health

Revenue Growth-11.60%
Profit Margin16.56%
P/E Ratio22.4
ROE5.24%
ROA2.35%
Debt/Equity48.13
P/B Ratio1.2
Op. Cash FlowA$2.8B
Free Cash FlowA$745.6M
Industry P/E21.5

Technical Analysis

TrendBullish
RSI60.1
SupportA$7.66
ResistanceA$8.24
MA 20A$7.94
MA 50A$7.84
MA 200A$7.06
MACDBullish
VolumeDecreasing
Fear & Greed Index89.91

Valuation

Fair ValueA$1.25
Target PriceA$8.94
Upside/Downside10.74%
GradeFair
TypeBlend
Dividend Yield4.32%

Risk Assessment

Beta-0.01
Volatility22.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.